Inhibition of pyruvate dehydrogenase kinase1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming.
Int J Oncol
; 57(3): 733-742, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32705170
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dicumarol
/
Carcinoma, Hepatocellular
/
Drug Resistance, Neoplasm
/
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
/
Liver Neoplasms
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Int J Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Country of publication:
Greece